Kligfield P, et al. Comparison of automated interval measurements by widely used algorithms in digital electrocardiographs. Am Heart J. 2014; 167(2): 150-159. e1.
Piccini J, et al. Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium. Am Heart J. 2017; 187: 156-169.
Turner JR, et al. The Cardiac Safety Research Consortium enters its second decade: An invitation to participate. Am Heart J. 2016; 177: 96-101.
Connie N. Hess, MD, MHSa; Mitchell W. Krucoff, MDa; Shubin Sheng, MSa; Kevin J. Anstrom, PhDa; W. Britt Barham, BAa; Ian C. Gilchrist, MDb; Robert A. Harrington, MDc; Alice K. Jacobs, MDd; Roxana Mehran, MDe; John C. Messenger, MDf; Daniel B. Mark, MDa; Sunil V. Rao, MDa; aDuke Clinical Research Institute, Durham, NC; bHeart & Vascular Institute, Pennsylvania State University, College of Medicine, Hershey, PA; cDepartment of Medicine, Stanford University, Stanford, CA; dDepartment of Medicine, Boston University School of Medicine, Boston, MA; eCardiovascular Research Foundation, Mount Sinai Medical Center, New York, NY; fDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO
Bates K, et al. Pediatric cardiovascular safety: Challenges in drug and
device development and clinical application. Am Heart J. 2012; 164(4): 481-492
Read the paper here: New precompetitive paradigms: Focus on cardiac safety
Finkle J, et al. New precompetitive paradigms: Focus on cardiac safety. Am Heart J. 2009; 157(5): 825-826
Piccini J, et al. Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the Critical Path Initiative. Am Heart J. 2009; 158(3): 317-326